Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China

• Κύριοι συγγραφείς: Jiaming Li (Συγγραφέας), Xinyue Zhang (Συγγραφέας), Rui Wang (Συγγραφέας), Keyao Cao (Συγγραφέας), Luhui Wan (Συγγραφέας), Xu Ren (Συγγραφέας), Jinxi Ding (Συγγραφέας), Wei Li (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

ObjectiveThis study aimed to evaluate the impact of the National Centralized Drug Procurement (NCDP) policy on chemical pharmaceutical enterprises' R&D investment and provide references for improving NCDP policy design and encouraging innovation in the pharmaceutical industry.MethodsUsing t...